American Research & Management Company’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $15K | Buy |
180
+15
| +9% | +$1.35K | ﹤0.01% | 275 |
|
|
2022
Q2 | $15K | Hold |
165
| – | – | ﹤0.01% | 276 |
|
|
2022
Q1 | $18K | Hold |
165
| – | – | ﹤0.01% | 276 |
|
|
2021
Q4 | $17K | Hold |
165
| – | – | ﹤0.01% | 275 |
|
|
2021
Q3 | $21K | Hold |
165
| – | – | ﹤0.01% | 261 |
|
|
2021
Q2 | $20K | Hold |
165
| – | – | ﹤0.01% | 273 |
|
|
2021
Q1 | $19K | Hold |
165
| – | – | ﹤0.01% | 256 |
|
|
2020
Q4 | $19K | Hold |
165
| – | – | ﹤0.01% | 262 |
|
|
2020
Q3 | $17K | Buy |
+165
| New | +$16.6K | 0.01% | 241 |
|
|
2020
Q2 | – | Sell |
-100
| Closed | -$9K | – | 357 |
|
|
2020
Q1 | $9K | Sell |
100
-500
| -83% | -$53.2K | ﹤0.01% | 261 |
|
|
2019
Q4 | $68K | Hold |
600
| – | – | 0.02% | 175 |
|
|
2019
Q3 | $65K | Hold |
600
| – | – | 0.02% | 185 |
|
|
2019
Q2 | $58K | Hold |
600
| – | – | 0.02% | 193 |
|
|
2019
Q1 | $55K | Buy |
600
+500
| +500% | +$44.8K | 0.02% | 206 |
|
|
2018
Q4 | $9K | Hold |
100
| – | – | ﹤0.01% | 277 |
|
|
2018
Q3 | $10K | Hold |
100
| – | – | ﹤0.01% | 290 |
|
|
2018
Q2 | $9K | Sell |
100
-50
| -33% | -$4.18K | ﹤0.01% | 272 |
|
|
2018
Q1 | $12K | Sell |
150
-478
| -76% | -$39.4K | ﹤0.01% | 289 |
|
|
2017
Q4 | $51K | Buy |
628
+478
| +319% | +$38.3K | 0.02% | 189 |
|
|
2017
Q3 | $12K | Hold |
150
| – | – | ﹤0.01% | 259 |
|
|
2017
Q2 | $13K | Hold |
150
| – | – | ﹤0.01% | 248 |
|
|
2017
Q1 | $12K | Sell |
150
-475
| -76% | -$37.1K | ﹤0.01% | 243 |
|
|
2016
Q4 | $45K | Hold |
625
| – | – | 0.02% | 182 |
|
|
2016
Q3 | $54K | Hold |
625
| – | – | 0.02% | 171 |
|
|
2016
Q2 | $54K | Sell |
625
-701
| -53% | -$56.7K | 0.02% | 160 |
|
|
2016
Q1 | $99K | Hold |
1,326
| – | – | 0.04% | 130 |
|
|
2015
Q4 | $102K | Sell |
1,326
-100
| -7% | -$7.53K | 0.04% | 131 |
|
|
2015
Q3 | $95K | Sell |
1,426
-251
| -15% | -$18.5K | 0.04% | 132 |
|
|
2015
Q2 | $124K | Buy |
1,677
+60
| +4% | +$4.58K | 0.05% | 125 |
|
|
2015
Q1 | $126K | Buy |
1,617
+692
| +75% | +$52.4K | 0.05% | 123 |
|
|
2014
Q4 | $67K | Hold |
925
| – | – | 0.02% | 157 |
|
|
2014
Q3 | $57K | Hold |
925
| – | – | 0.02% | 170 |
|
|
2014
Q2 | $59K | Hold |
925
| – | – | 0.02% | 170 |
|
|
2014
Q1 | $57K | Hold |
925
| – | – | 0.02% | 168 |
|
|
2013
Q4 | $53K | Sell |
925
-65
| -7% | -$3.69K | 0.02% | 171 |
|
|
2013
Q3 | $53K | Sell |
990
-300
| -23% | -$16.1K | 0.02% | 166 |
|
|
2013
Q2 | $66K | Buy |
+1,290
| New | +$63.8K | 0.03% | 152 |
|
Other funds holding MDT
American Research & Management Company's MDT Position: Q3 2022 in Review
American Research & Management Company increased its Medtronic (MDT) stake by 9.1% in Q3 2022, buying an estimated $1.35K and bringing the position to 180 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #275.
American Research & Management Company first reported a position in MDT in Q2 2013 and has held it in 37 quarters since. The position peaked at $126K in Q1 2015. 1,931 funds tracked by Wall St. Rank hold MDT as of Q3 2022.
- American Research & Management Company held 180 shares of Medtronic worth $15K as of Q3 2022.
- American Research & Management Company bought 15 Medtronic shares in Q3 2022, an estimated $1.35K.
- Medtronic made up ﹤0.01% of American Research & Management Company's portfolio in Q3 2022, its #275 holding.
- American Research & Management Company first reported a position in Medtronic in Q2 2013 and has held it in 37 quarters since.
- American Research & Management Company's Medtronic position peaked at $126K in Q1 2015.
- 1,931 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.
Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.